Toru Kondo

Dapagliflozin for heart failure according to body mass index: the DELIVER trial

Carly Adamson, Toru Kondo, Pardeep S. Jhund et al. · European Heart Journal · 2022 · 146 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Late-Onset Fulminant Myocarditis With Immune Checkpoint Inhibitor Nivolumab

Shogo Yamaguchi, Ryota Morimoto, Takahiro Okumura et al. · Canadian Journal of Cardiology · 2018 · 75 citations

Life Sciences, Immunology, Internal Medicine +14

Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction

Akshay S. Desai, Pardeep S. Jhund, Brian Claggett et al. · JAMA Cardiology · 2022 · 61 citations · Full text

Medicine, Cardiology, Pharmacology +17

Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the <scp>EMPEROR</scp> –Preserved trial

Stuart Pocock, João Pedro Ferreira, Milton Packer et al. · European Journal of Heart Failure · 2022 · 53 citations · Full text

Medicine, Biostatistics, Cardiology +17

Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?

Toru Kondo, Pooja Dewan, Inder S. Anand et al. · Circulation · 2023 · 47 citations · Full text

Medicine, Cardiology, Clinical Cardiology +13